Aseptic/Sterile Processing

Looking Back at 2021 Pharma Manufacturing Topics

December 13, 2021

New processes, automation, and digitalization were highlighted in 2021.

Trends in Isolator Equipment

December 03, 2021

Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

December 02, 2021

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

Evolution of Aseptic Processing: INTERPHEX Keynote Part 5

November 19, 2021

Jordi Serrat, Product & Technology Director, Azbil Telstar talks about the role of disruptive and digital technologies in aseptic processing.

Evolution of Aseptic Processing: INTERPHEX Keynote Part 4

November 18, 2021

Rafael Beaus, Global Consultancy Manager, Azbil Telstar, discusses Annex 1 and trends in aseptic production.

Evolution of Aseptic Processing: INTERPHEX Keynote Part 3

November 17, 2021

Luke Stockhausen, Lead Process Engineer, CRB, talks about technological advances, processing line changes, and new solutions to overcome challenges in aseptic processing.

Evolution of Aseptic Processing: INTERPHEX Keynote Part 2

November 16, 2021

Richard Denk, Senior Consultant Aseptic Processing and Containment, SKAN AG, discusses the evolution of aseptic processing with a particular focus on isolators.

Equipment Innovations for Pharma Manufacturing

November 15, 2021

Trends and technologies in pharmaceutical manufacturing were highlighted on the show floor and in the conference sessions on the INTERPHEX Innovation Stage.

Evolution of Aseptic Processing: INTERPHEX Keynote Part 1

November 15, 2021

Patrick Nieuwenhuizen, Senior Manager/Consultant, PharmaLex, discusses changes to regulatory requirements, quality risk management, audits, and operational considerations of aseptic processing.

TCR² Therapeutics Announces Expansion of US Manufacturing Capacity

November 04, 2021

TCR² Therapeutics will add a second clean room to their manufacturing operations.